Fat and carbohydrate in western diet contribute differently to hepatic lipid accumulation

Biochemical and Biophysical Research Communications

Volumn 461, Issue 4, 2015, Pages 681-686

  Wu, Wudelehu ^a   Tsuchida, Hiromi ^a   Kato, Takehiro ^a,b   Niwa, Horoyuki ^a   Horikawa, Yukio ^a   Takeda, Jun ^a   Iizuka, Katsumi ^a,c  

^a GIFU UNIVERSITY   (Japan)

^b Matsunami General Hospital   (Japan)

^c GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

ChREBP; FGF21; Hepatic steatosis; Ketogenesis; VLDL; oxidation

Indexed keywords

CARBOHYDRATE DIET; FAT INTAKE; MLXIPL PROTEIN, MOUSE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; C57BL MOUSE; CARBOHYDRATE DIET; FAT INTAKE; FATTY LIVER; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; PHYSIOLOGY; WESTERN DIET;

ANIMALS; DIET, WESTERN; DIETARY CARBOHYDRATES; DIETARY FATS; FATTY LIVER; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84937759992     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.04.092     Document Type: Article

References (39)

1. M. Gaggini, M. Morelli, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 2013 1544 1560
2. J.M. Kneeman, J. Misdraji, and K.E. Corey Secondary causes of nonalcoholic fatty liver disease Ther. Adv. Gastroenterol. 5 2012 199 207
3. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest. 114 2004 147 152
4. M. Asrih, and F.R. Jornayvaz Diets and nonalcoholic fatty liver disease: the good and the bad Clin. Nutr. 33 2014 186 190
5. K. Iizuka, and Y. Horikawa ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome Endocr. J. 55 2008 617 624
6. K. Uyeda, and J.J. Repa Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis Cell. Metab. 4 2006 107 110
7. K. Iizuka Recent progress on the role of ChREBP in glucose and lipid metabolism Endocr. J. 60 2013 543 555
8. K. Iizuka, B. Miller, and K. Uyeda Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice Am. J. Physiol. Endocrinol. Metab. 291 2006 E358 E364
9. R. Dentin, F. Benhamed, I. Hainault, V. Fauveau, F. Foufelle, J.R. Dyck, J. Girard, and C. Postic Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice Diabetes 55 2006 2159 2170
10. S.C. Burgess, K. Iizuka, N.H. Jeoung, R.A. Harris, Y. Kashiwaya, R.L. Veech, T. Kitazume, and K. Uyeda Carbohydrate-response element-binding protein deletion alters substrate utilization producing an energy-deficient liver J. Biol. Chem. 283 2008 1670 1678
11. T. Kawaguchi, K. Osatomi, H. Yamashita, T. Kabashima, and K. Uyeda mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase J. Biol. Chem. 277 2002 3829 3835
12. K. Iizuka, R.K. Bruick, G. Liang, J.D. Horton, and K. Uyeda Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis Proc. Natl. Acad. Sci. U. S. A. 101 2004 7281 7286
13. E.G. Bligh, and W.J. Dyer A rapid method for total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
14. K. Iizuka, and Y. Horikawa Regulation of lipogenesis via BHLHB2/DEC1 and ChREBP feedback looping Biochem. Biophys. Res. Commun. 374 2008 95 100
15. K. Iizuka, W. Wu, Y. Horikawa, M. Saito, and J. Takeda Feedback looping between ChREBP and PPARα in the regulation of lipid metabolism in brown adipose tissues Endocr. J. 60 2013 1145 1153
16. K. Iizuka, J. Takeda, and Y. Horikawa Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes FEBS Lett. 583 2009 2882 2886
17. L. Ma, L.N. Robinson, and H.C. Towle ChREBP∗Mlx is the principal mediator of glucose-induced gene expression in the liver J. Biol. Chem. 281 2006 28721 28730
18. A.J. Van Wettere, J.M. Law, D.E. Hinton, and S.W. Kullman Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injury Toxicol. Pathol. 41 2013 744 760
19. X.M. Meng, X.R. Huang, A.C. Chung, W. Qin, X. Shao, P. Igarashi, W. Ju, E.P. Bottinger, and H.Y. Lan Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis J. Am. Soc. Nephrol. 21 2010 1477 1487
20. Y.A. Moon, R.E. Hammer, and J.D. Horton Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice J. Lipid Res. 50 2009 412 423
21. M.A. Herman, O.D. Peroni, J. Villoria, M.R. Schön, N.A. Abumrad, M. Blüher, S. Klein, and B.B. Kahn A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism Nature 484 2012 333 338
22. R. Martínez-Beamonte, M.A. Navarro, S. Acin, N. Guillén, C. Barranquero, C. Arnal, J. Surra, and J. Osada Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil PLoS One 8 2013 e55231
23. E.E. Mulvihill, J.M. Assini, J.K. Lee, E.M. Allister, B.G. Sutherland, J.B. Koppes, C.G. Sawyez, J.Y. Edwards, D.E. Telford, A. Charbonneau, P. St-Pierre, A. Marette, and M.W. Huff Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance Diabetes 60 2011 1446 1457
24. J.E. Bowe, Z.J. Franklin, A.C. Hauge-Evans, A.J. King, S.J. Persaud, and P.M. Jones Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models J. Endocrinol. 222 2014 G13 G25
25. B.S. Hijmans, A. Grefhorst, M.H. Oosterveer, and A.K. Groen Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences Biochimie 96 2014 121 129
26. M.J. Potthoff, S.A. Kliewer, and D.J. Mangelsdorf Endocrine fibroblast growth factors 15/19 and 21: from feast to famine Genes. Dev. 26 2012 312 324
27. A.C. Adams, and A. Kharitonenkov FGF21: the center of a transcriptional nexus in metabolic regulation Curr. Diabetes Rev. 8 2012 285 293
28. A. Kharitonenkov, and A.C. Adams Inventing new medicines: the FGF21 story, Molecular Metabolism 3 2014 221 229
29. K. Mai, J. Andres, K. Biedasek, J. Weicht, T. Bobbert, M. Sabath, S. Meinus, F. Reinecke, M. Möhlig, M.O. Weickert, M. Clemenz, A.F. Pfeiffer, U. Kintscher, S. Spuler, and J. Spranger Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth Factor-21 Diabetes 58 2009 1532 1538
30. M.K. Badman, A. Koester, J.S. Flier, A. Kharitonenkov, and E. Maratos-Flier Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis Endocrinology 150 2009 4931 4940
31. F. Benhamed, P.D. Denechaud, M. Lemoine, C. Robichon, M. Moldes, J. Bertrand-Michel, V. Ratziu, L. Serfaty, C. Housset, J. Capeau, J. Girard, H. Guillou, and C. Postic The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans J. Clin. Invest 122 2012 2176 2194
32. C. Xiao, S. Dash, C. Morgantini, and G.F. Lewis New and emerging regulators of intestinal lipoprotein secretion Atherosclerosis 233 2014 608 615
33. A. Uchida, M.C. Whitsitt, T. Eustaquio, M.N. Slipchenko, J.F. Leary, J.X. Cheng, and K.K. Buhman Reduced triglyceride secretion in response to an acute dietary fat challenge in obese compared to lean mice Front. Physiol. 3 2012 26
34. C.L. Yen, D.W. Nelson, and M.I. Yen Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism J. Lipid Res. 2014 Sep 17 pii: jlr.R052902
35. J. Iqbal, and M.M. Hussain Intestinal lipid absorption Am. J. Physiol. Endocrinol. Metab. 296 2009 E1183 E1194
36. I. Khatun, S. Zeissig, J. Iqbal, M. Wang, D. Curiel, G.S. Shelness, R.S. Blumberg, and M.M. Hussain Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice Hepatology 55 2012 1356 1368
37. M.M. Hussain, J. Shi, and P. Dreizen Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly J. Lipid. Res. 44 2013 22 32
38. A.R. Kennedy, P. Pissios, H. Otu, R. Roberson, B. Xue, K. Asakura, N. Furukawa, F.E. Marino, F.F. Liu, B.B. Kahn, T.A. Libermann, and E. Maratos-Flier A high-fat, ketogenic diet induces a unique metabolic state in mice Am. J. Physiol. Endocrinol. Metab 292 2007 E1724 E1739
39. T. Hendrikx, S.M. Walenbergh, M.H. Hofker, and R. Shiri-Sverdlov Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis Obes. Rev. 15 2014 424 433